- Home
- VSTM vs EVM Comparison
VSTM vs EVM Comparison
Compare VSTM & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- EVM
- Stock Information
- Founded
- VSTM 2010
- EVM 2002
- Country
- VSTM United States
- EVM United States
- Employees
- VSTM N/A
- EVM N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- EVM Finance/Investors Services
- Sector
- VSTM Health Care
- EVM Finance
- Exchange
- VSTM Nasdaq
- EVM Nasdaq
- Market Cap
- VSTM 263.5M
- EVM 230.9M
- IPO Year
- VSTM 2012
- EVM N/A
- Fundamental
- Price
- VSTM $7.20
- EVM $9.34
- Analyst Decision
- VSTM Strong Buy
- EVM
- Analyst Count
- VSTM 8
- EVM 0
- Target Price
- VSTM $12.67
- EVM N/A
- AVG Volume (30 Days)
- VSTM 806.1K
- EVM 55.8K
- Earning Date
- VSTM 03-21-2025
- EVM 01-01-0001
- Dividend Yield
- VSTM N/A
- EVM 4.01%
- EPS Growth
- VSTM N/A
- EVM N/A
- EPS
- VSTM N/A
- EVM 0.20
- Revenue
- VSTM $10,000,000.00
- EVM N/A
- Revenue This Year
- VSTM N/A
- EVM N/A
- Revenue Next Year
- VSTM $117.91
- EVM N/A
- P/E Ratio
- VSTM N/A
- EVM $47.61
- Revenue Growth
- VSTM N/A
- EVM N/A
- 52 Week Low
- VSTM $2.10
- EVM $7.67
- 52 Week High
- VSTM $13.52
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- VSTM 77.09
- EVM 51.57
- Support Level
- VSTM $5.40
- EVM $9.27
- Resistance Level
- VSTM $7.50
- EVM $9.41
- Average True Range (ATR)
- VSTM 0.43
- EVM 0.06
- MACD
- VSTM 0.19
- EVM -0.00
- Stochastic Oscillator
- VSTM 97.38
- EVM 68.75
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.